Renckens R, Roelofs J J T H, Stegenga M E, Florquin S, Levi M, Carmeliet P, Van't Veer C, van der Poll T
Center for Infection and Immunity Amsterdam (CINIMA), and Center for Experimental and Molecular Medicine, University of Amsterdam, Amsterdam, The Netherlands.
J Thromb Haemost. 2008 Apr;6(4):660-8. doi: 10.1111/j.1538-7836.2008.02892.x. Epub 2008 Jan 9.
Severe pneumonia is associated with a local inhibition of fibrinolysis in the lung as reflected by strongly reduced pulmonary plasminogen activator activity.
To study the effect of elevation of local plasminogen activator activity during pneumonia caused by the common respiratory pathogen Klebsiella pneumoniae.
Female C57Bl/6 mice were inoculated intranasally with a replication-defective adenoviral vector expressing human tissue-type plasminogen activator or a control vector 24 h before intranasal infection with K. pneumoniae.
Mice infected with Klebsiella via the airways developed overt pneumonia, which was accompanied by a downregulation of pulmonary tissue-type plasminogen activator levels at protein and mRNA levels. Pulmonary overexpression of human tissue-type plasminogen activator resulted in increased fibrinolytic activity in the lungs during pneumonia, as indicated by higher D-dimer levels and reduced fibrin deposition. Interestingly, overexpression of tissue-type plasminogen activator markedly improved host defense against pneumonia: mice treated with the tissue-type plasminogen activator vector displayed less bacterial growth and dissemination, attenuated distant organ injury and a reduced mortality.
These data demonstrate that local elevation of plasminogen activator activity in the lungs improves host defense against severe gram-negative pneumonia and sepsis.
严重肺炎与肺内纤维蛋白溶解的局部抑制有关,这表现为肺组织纤溶酶原激活物活性显著降低。
研究常见呼吸道病原体肺炎克雷伯菌所致肺炎期间局部纤溶酶原激活物活性升高的影响。
雌性C57Bl/6小鼠在经鼻感染肺炎克雷伯菌前24小时,经鼻接种表达人组织型纤溶酶原激活物的复制缺陷型腺病毒载体或对照载体。
经气道感染克雷伯菌的小鼠发生明显的肺炎,同时肺组织型纤溶酶原激活物水平在蛋白质和mRNA水平均下调。人组织型纤溶酶原激活物在肺内的过表达导致肺炎期间肺内纤维蛋白溶解活性增加,表现为D-二聚体水平升高和纤维蛋白沉积减少。有趣的是,组织型纤溶酶原激活物的过表达显著改善了宿主对肺炎的防御:用组织型纤溶酶原激活物载体处理的小鼠细菌生长和播散减少,远处器官损伤减轻,死亡率降低。
这些数据表明,肺内纤溶酶原激活物活性的局部升高可改善宿主对严重革兰阴性菌肺炎和脓毒症的防御。